Ceva Animal Health unveils new global headquarters

CEVA Animal Health, the world’s fifth-largest animal health company, has unveiled its new global headquarters in Libourne, France.

The eye-catching circular building serves as a global showcase for the company, embodying sustainability, commitment to employees and the firm's business aspirations, such as leading in poultry vaccines and developing treatments for emerging diseases.

Envisioned as early as 2020, the new headquarters hosts 450 staff across 11,000 m² and four floors, bringing together the group’s main strategic functions.

Created as part of Ceva’s #OnePlanet initiative, it underscores the company's commitment to biodiversity and environmental balance.

Designed to reflect the company’s logo, the building features a tree-like form with a 1,300 m² green roof, integrating seamlessly into the landscape as a biodiversity haven.

Staff helped design Ceva's new headquarters

Beyond its local economic impact, the project was also designed as an environmental lever, favouring short supply chains, low-carbon materials and sustainable construction practices.

The building is powered by geothermal systems and 4,500 m² of solar panels installed over the car park, meeting all its electricity needs.

Designed collaboratively with employees through co-design workshops, it also emphasises accessibility, with step-free access, pedestrian walkways and bicycle parking.

Dr Marc Prikazsky, Ceva’s chairman and CEO, said: “The opening of our new global headquarters marks a pivotal moment in Ceva's journey as a leader in animal health.

“This state-of-the-art facility unites key strategic functions, reinforcing our strong European and worldwide market position. It embodies our core beliefs and commitment to innovation, driving us towards a more connected and sustainable future in animal health.”

Ceva now operates in 47 countries and employs more than 7,000 people worldwide. Its European presence includes 10 R&D centres and 13 production sites, featuring advanced vaccine facilities in the UK, Germany, and France.